Literature DB >> 25535666

West Nile virus-specific immunoglobulin isotype responses in vaccinated and infected horses.

Sarah M Khatibzadeh1, Carvel B Gold, Alison E Keggan, Gillian A Perkins, Amy L Glaser, Edward J Dubovi, Bettina Wagner.   

Abstract

OBJECTIVE: To compare antibody responses of horses naturally infected with West Nile virus (WNV) and those vaccinated against WNV, to identify whether vaccination interferes with the ability to diagnose WNV infection, and to determine the duration of antibody responses after vaccination. SAMPLE: Sera from horses naturally infected with WNV (n = 10) and adult WNV-naïve horses before and after vaccination with a live canarypox virus-vectored vaccine (7) or a killed virus vaccine (8). PROCEDURES: An established WNV IgM capture ELISA was used to measure IgM responses. Newly developed capture ELISAs were used to measure responses of 8 other WNV-specific immunoglobulin isotypes. A serum neutralization assay was used to determine anti-WNV antibody titers.
RESULTS: WNV-specific IgM responses were typically detected in the sera of WNV-infected horses but not in sera of horses vaccinated against WNV. Natural infection with and vaccination against WNV induced an immunoglobulin response that was primarily composed of IgG1. West Nile virus-specific IgG1 was detected in the sera of most horses 14 days after vaccination. Serum anti-WNV IgG1 and neutralizing antibody responses induced by the killed-virus vaccines were higher and lasted longer than did those induced by the live canarypox virus-vectored vaccine. CONCLUSIONS AND CLINICAL RELEVANCE: On the basis of these findings, we recommend that horses be vaccinated against WNV annually near the beginning of mosquito season, that both IgM and IgG1 responses against WNV be measured to distinguish between natural infection and vaccination, and that a WNV IgG1 ELISA be used to monitor anti-WNV antibodies titers in vaccinated horses.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25535666     DOI: 10.2460/ajvr.76.1.92

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  8 in total

1.  West Nile virus in horses - What do you need to know to diagnose the disease?

Authors:  Julie Paré; Alison Moore
Journal:  Can Vet J       Date:  2018-10       Impact factor: 1.008

2.  Equine Arteritis Virus Elicits a Mucosal Antibody Response in the Reproductive Tract of Persistently Infected Stallions.

Authors:  Mariano Carossino; Bettina Wagner; Alan T Loynachan; R Frank Cook; Igor F Canisso; Lakshman Chelvarajan; Casey L Edwards; Bora Nam; John F Timoney; Peter J Timoney; Udeni B R Balasuriya
Journal:  Clin Vaccine Immunol       Date:  2017-10-05

3.  Improved reliability of serological tools for the diagnosis of West Nile fever in horses within Europe.

Authors:  Cécile Beck; Steeve Lowenski; Benoit Durand; Céline Bahuon; Stéphan Zientara; Sylvie Lecollinet
Journal:  PLoS Negl Trop Dis       Date:  2017-09-15

4.  Amino acid 159 of the envelope protein affects viral replication and T-cell infiltration by West Nile virus in intracranial infection.

Authors:  Shintaro Kobayashi; Chisato Kaneko; Ryoko Kawakami; Rie Hasebe; Hirofumi Sawa; Kentaro Yoshii; Hiroaki Kariwa
Journal:  Sci Rep       Date:  2020-04-28       Impact factor: 4.379

5.  Seroprevalence of West Nile and Usutu viruses in military working horses and dogs, Morocco, 2012: dog as an alternative WNV sentinel species?

Authors:  B Durand; H Haskouri; S Lowenski; N Vachiery; C Beck; S Lecollinet
Journal:  Epidemiol Infect       Date:  2016-02-03       Impact factor: 4.434

6.  Postmortem diagnoses of spinal ataxia in 316 horses in California.

Authors:  Erin N Hales; Monica Aleman; Sabin A Marquardt; Scott A Katzman; Kevin D Woolard; Andrew D Miller; Carrie J Finno
Journal:  J Am Vet Med Assoc       Date:  2021-06-15       Impact factor: 1.836

7.  Equine seroprevalence of West Nile virus antibodies in the UK in 2019.

Authors:  Arran J Folly; Elisabeth S L Waller; Fiona McCracken; Lorraine M McElhinney; Helen Roberts; Nicholas Johnson
Journal:  Parasit Vectors       Date:  2020-11-26       Impact factor: 3.876

Review 8.  Equids' Core Vaccines Guidelines in North America: Considerations and Prospective.

Authors:  Hélène Desanti-Consoli; Juliette Bouillon; Ronan J J Chapuis
Journal:  Vaccines (Basel)       Date:  2022-03-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.